Byline Bancorp, Inc. (BY)
Live price chart, market sentiment, and community perspectives for Byline Bancorp, Inc. (NYSE: BY).
Live price chart, market sentiment, and community perspectives for Byline Bancorp, Inc. (NYSE: BY).
On our fundamental desk, Byline Bancorp's Q2 2026 presentation stood out immediately with record profits and the highest operational efficiency ratio achieved since their 2017 IPO. With 3 Buy ratings and 3 Hold ratings driving a Moderate Buy consensus and a $43.00 price target, the valuation is looking compelling against the recent $38–$39 trading band. However, we are carefully watching valuation expansion limits given the broader regional banking environment.
From a quantitative perspective using alternative data signals from platforms like AltIndex, BY holds a steady 54 to 55 out of 100 AI Score translating to a Hold rating. Even though web traffic metrics have ticked up slightly over the trailing 90 days—showing a modest bump in monthly visits—the brand and employment alternative indicators remain flat at zero, suggesting we lack the retail demand momentum needed for an aggressive long breakout.
Scanning the latest TrendMatrix and 10-K data disclosures for BY, the core deposit concentration level sitting at 87% is an unmistakable headline risk. While robust fund flow characteristics and a liquidity flow evaluation score of 7.53 out of 10 provide short-term comfort, this heavy deposit exposure requires strict monitoring by our risk management team during any unexpected rate shifts.
Reviewing the options and liquidity landscape for Byline Bancorp, the lack of heavy institutional chatter keeps the name off our aggressive momentum screens. With a $2B market cap and a trailing P/E ratio hovering around 12.5 to 12.6, the equity is fairly valued as a defensive regional bank play, but it lacks the explosive technical catalysts required for short-dated option plays.
As a portfolio manager tracking Chicago-area financials, Byline's execution on cost controls and efficiency gains this quarter was text-book. Earnings coming up on October 21 will be the real test to see if management can sustain these record margins against tightening net interest spreads across the regional banking sector.
Explore plasma cleansing, somatic organ swaps, and BCI.